About
Academic Title: Professor of Pathology and Laboratory Medicine
Department Title: Director of Hematopathology Fellowship Program
Specialty: Hematopathology & Hematology
Languages
Education
Medical Board Certifications
Hematopathology, American Board of Pathology, 2017
Pathology-Anatomic/Pathology-Clinical, American Board of Pathology, 2005
Fellowships
Hematopathology, LAC + USC Medical Center, 2006
Surgical Pathology, LAC + USC Medical Center, 2005
Research-Oncology, LAC + USC Medical Center, 2000
Residency
Pathology, LAC + USC Medical Center, 2004
Internship
Rotating Internship, Calicut Medical College, 1994
Degree
MBBS, Calicut Medical College, 1993
Hospital Affiliations
Ronald Reagan UCLA Medical Center
Research
Interests
- Chemokine receptors in hematological malignancies
- Systemic mastocytosis
Publications
- Pullarkat ST, Wu W, Pullarkat V (2021). Cancer Treatment Research Systemic Mastocytosis: Advances in Diagnosis and Current Management. PMID: 3462636.
- Ustun C, Morgan E, Moosie EM, Ritz EM, Vestergaard H, Pullarkat ST, Kluin PM et al (2020). Core- Binding Factor Acute Myeloid Leukemia with inv (16): Older Age and High White Blood Cell Count are Risk Factors for Treatment failure. Int J Lab Hematol. Sep 14. doi: 10.1111/ijlh.13338.PMID: 32926565.
- Han SY, Mrozek K, Voutsinas J et al. (2020). Differences in Secondary Cytogenetic Abnormalities Between Core Binding Factor AML who harbor inv (16) versus t(8;21). ADV-2020-003605R2. Blood Advances. PMID: 34003250.
- Lee C, Asilnejad B, Roelofs K, Khanlou N, Rootman D, Pullarkat ST (2022) Solitary Extramedullary Plasmacytoma of the Lacrimal Sac with Associated Crystal Storing Histiocytosis. Journal of Ophthalmic Plastic and Reconstructive Surgery 38(2):102-107. PMID: 35390768.
- Lollie TK, Parks R, Bakic L, Ziman A, Pullarkat S. (2022). Educational cost-effective intervention to reduce pathologist peripheral blood smear reviews with non-contributory findings: an academic institution experience. J Clin Pathol; 75(3): 154-158. PMID: 34406151.
- Dietz R, Lollie T, Goh T, Rao N, Pullarkat ST (2022). Comparison of laboratory methods for the detection of neoplastic plasma cells in plasma cell dyscrasias. J Clin Pathol (ahead of print)
- Wu W, Doan B, Said JS, Pullarkat ST. . Human Pathology 2014; 45: 1451-58.
- DeNicola M, Shabsovich D, Pullarkat ST et al. Hyperdiploidy in CLL/SLL: A rare cytogenetic event associated with poor prognosis. The Journal of the Association of Genetic Technology 40(1) 2014.
- Ji J, Loo E, Pullarkat S, Yang L, Tirado CA. . Exp Hematol Oncol 2014; 19: (1) 8.
- Pullarkat ST, Pullarkat V, Lagoo A et al. . Leukemia Research 2013; 37: 1572-75
- DeNicola M, Said JW, Pullarkat ST. . Journal of hematological Malignancies 2013; 3: (1) 28-34.
- Mitton B, Olivera S, Pullarkat ST, Moore TB. . J Pediatr Hematol Oncol 2013;35 (3) e120-2.
- Mbuileteye S, Pullarkat ST, Nathwani BS et. al . APIMS 2014; 122: 5-15.
- Alexanian S, Said J, Lones M, Pullarkat ST. . Am J Surg Pathol 2013; 37: 241-49.
- Acree SC, Pullarkat, ST, Quismorio F P, Mian SR, Brynes RK. . J Clin Rheumatology 2011; 17: 130-4.
- Wong AK, Kerkoutian S, Rashidi H, Said J, Pullarkat ST. Anti- TNF therapy in patients with rheumatoid arthritis is not associated with increased risk of lymphoma. Clinical Rheumatology 2012; 31:631-636.
- Alexanian S, Wong A, Said J, Aoyoma C, Park A, Pullarkat ST. . J Hematopathol 2010; 3: 161-165.
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- L.A. Care
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.